- 1. Career
Ginger L. Graham is Former President and Chief Executive Officer at Amylin Pharmaceuticals.
She previously served as Senior Lecturer at Harvard Business School from October 2009 to June 2012.
She also previously served as President (from September 2003 to June 2006) and Chief Executive Officer (from September 2003 to March 2007) of Amylin Pharmaceuticals, a biopharmaceutical company, where she also served as a Director from 1995 to 2009. From 1994 to 2003, she held various positions at Guidant Corporation, a cardiovascular medical device manufacturer, including Group Chairman, Office of the President, President of the Vascular Intervention Group, and Vice President.
Ms. Graham has served on the board of directors of Clovis Oncology, Inc. since 2013 and has served as the chair since 2019. From 2018 to 2020, she served on the board of directors of Genomic Health, Inc.